Cervical Cancer Vaccine, Made In India, To Be Available Soon At Rs 200-400

Union Minister of Science and Technology Jitendra Singh today attended an event held to announce the scientific completion of the vaccine. Scientific completion implies that the R&D activities pertaining to the vaccine are complete and the next step would be making them available to the public.

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched in a few months and made available to the people in the affordable price range of Rs 200-400.

Union Minister of Science and Technology Jitendra Singh today attended an event held to announce the scientific completion of the vaccine. Scientific completion implies that the R&D activities pertaining to the vaccine are complete and the next step would be making them available to the public.

Speaking at the event, Mr Singh said Covid has raised awareness about preventive healthcare leading to the development of vaccines like the one against cervical cancer.

"The schemes like Ayushman Bharat have made us think about preventive healthcare and we can now afford it. The Department of Biotechnology has taken a lead in the matter and are in collaborative mode," he said.